Pfenex Inc. (PFNX) On Track To Operating Profitability - William Blair

William Blair analyst, Andy Hsieh, reiterated an Outperform rating on Pfenex Inc. (NYSE: PFNX) after the company reported a smaller loss than expected. EPS of -$0.22 was above the Street’s estimate of a loss per share of -$0.35 due to lower-than-expected R&D spending.

The analyst stated "we expect approval of PF708 by October 7. We believe upon approval, PF708 could provide Pfenex with significant cash flow that culminates in operating profitability by the end of 2020".

For an analyst ratings summary and ratings history on Pfenex Inc. click here. For more ratings news on Pfenex Inc. click here.

Shares of Pfenex Inc. closed at $4.72 yesterday.

You May Also Be Interested In

• Goldman Sachs Upgrades Plains GP Holdings, L.P (PAGP) to Neutral
• BorgWarner (BWA) PT Raised to $95 at Wolfe Research, 'Bullish Takeaways from CEO Meetings'
• Freedom Broker Starts Norwegian Cruise (NCLH) at Buy